vs
Side-by-side financial comparison of Graham Holdings Co (GHC) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Graham Holdings Co). Graham Holdings Co runs the higher net margin — 8.7% vs 4.4%, a 4.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 0.4%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $5.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 4.2%).
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
GHC vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $108.7M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 3.8% | 12.4% |
| Net Margin | 8.7% | 4.4% |
| Revenue YoY | 0.4% | 32.8% |
| Net Profit YoY | -80.2% | 143.8% |
| EPS (diluted) | $24.76 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.2B | $929.2M | ||
| Q1 24 | $1.2B | $751.7M |
| Q4 25 | $108.7M | $66.5M | ||
| Q3 25 | $122.9M | $124.8M | ||
| Q2 25 | $36.7M | $94.3M | ||
| Q1 25 | $23.9M | $1.3M | ||
| Q4 24 | $548.8M | $-151.9M | ||
| Q3 24 | $72.5M | $-121.3M | ||
| Q2 24 | $-21.0M | $-120.4M | ||
| Q1 24 | $124.4M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 3.8% | 12.4% | ||
| Q3 25 | 5.2% | 11.5% | ||
| Q2 25 | 6.0% | 6.7% | ||
| Q1 25 | 4.1% | 1.0% | ||
| Q4 24 | 5.8% | -7.0% | ||
| Q3 24 | 6.8% | -12.0% | ||
| Q2 24 | 2.2% | -11.5% | ||
| Q1 24 | 3.1% | -34.8% |
| Q4 25 | 8.7% | 4.4% | ||
| Q3 25 | 9.6% | 8.8% | ||
| Q2 25 | 3.0% | 7.2% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 44.1% | -13.5% | ||
| Q3 24 | 6.0% | -12.1% | ||
| Q2 24 | -1.8% | -13.0% | ||
| Q1 24 | 10.8% | -33.4% |
| Q4 25 | $24.76 | $0.05 | ||
| Q3 25 | $27.91 | $0.08 | ||
| Q2 25 | $8.35 | $0.06 | ||
| Q1 25 | $5.45 | $0.00 | ||
| Q4 24 | $124.05 | $-0.10 | ||
| Q3 24 | $16.42 | $-0.09 | ||
| Q2 24 | $-4.79 | $-0.09 | ||
| Q1 24 | $27.72 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $267.0M | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $4.8B | $4.4B |
| Total Assets | $8.4B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0M | $4.5B | ||
| Q3 25 | $190.8M | $4.0B | ||
| Q2 25 | $176.2M | $2.8B | ||
| Q1 25 | $156.7M | $2.5B | ||
| Q4 24 | $260.9M | $2.6B | ||
| Q3 24 | $244.4M | $2.7B | ||
| Q2 24 | $140.7M | $2.6B | ||
| Q1 24 | $130.9M | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $4.8B | $4.4B | ||
| Q3 25 | $4.5B | $4.1B | ||
| Q2 25 | $4.4B | $3.8B | ||
| Q1 25 | $4.3B | $3.5B | ||
| Q4 24 | $4.3B | $3.3B | ||
| Q3 24 | $4.0B | $3.4B | ||
| Q2 24 | $4.0B | $3.4B | ||
| Q1 24 | $4.0B | $3.4B |
| Q4 25 | $8.4B | $8.2B | ||
| Q3 25 | $7.9B | $7.6B | ||
| Q2 25 | $7.6B | $6.3B | ||
| Q1 25 | $7.6B | $5.8B | ||
| Q4 24 | $7.7B | $5.9B | ||
| Q3 24 | $7.4B | $5.8B | ||
| Q2 24 | $7.2B | $5.7B | ||
| Q1 24 | $7.3B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.3M | $417.3M |
| Free Cash FlowOCF − Capex | $5.0M | $379.8M |
| FCF MarginFCF / Revenue | 0.4% | 25.4% |
| Capex IntensityCapex / Revenue | 1.9% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.26× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $275.3M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.3M | $417.3M | ||
| Q3 25 | $178.1M | $402.6M | ||
| Q2 25 | $94.8M | $263.6M | ||
| Q1 25 | $46.0M | $44.1M | ||
| Q4 24 | $116.3M | $75.2M | ||
| Q3 24 | $237.6M | $188.4M | ||
| Q2 24 | $52.0M | $-95.6M | ||
| Q1 24 | $1.1M | $-308.6M |
| Q4 25 | $5.0M | $379.8M | ||
| Q3 25 | $161.8M | $354.5M | ||
| Q2 25 | $78.0M | $219.8M | ||
| Q1 25 | $30.5M | $-12.3M | ||
| Q4 24 | $91.1M | $-17.3M | ||
| Q3 24 | $219.4M | $54.7M | ||
| Q2 24 | $33.7M | $-205.5M | ||
| Q1 24 | $-20.2M | $-465.1M |
| Q4 25 | 0.4% | 25.4% | ||
| Q3 25 | 12.6% | 25.1% | ||
| Q2 25 | 6.4% | 16.7% | ||
| Q1 25 | 2.6% | -1.1% | ||
| Q4 24 | 7.3% | -1.5% | ||
| Q3 24 | 18.2% | 5.5% | ||
| Q2 24 | 2.8% | -22.1% | ||
| Q1 24 | -1.8% | -61.9% |
| Q4 25 | 1.9% | 2.5% | ||
| Q3 25 | 1.3% | 3.4% | ||
| Q2 25 | 1.4% | 3.3% | ||
| Q1 25 | 1.3% | 5.0% | ||
| Q4 24 | 2.0% | 8.2% | ||
| Q3 24 | 1.5% | 13.3% | ||
| Q2 24 | 1.5% | 11.8% | ||
| Q1 24 | 1.8% | 20.8% |
| Q4 25 | 0.26× | 6.28× | ||
| Q3 25 | 1.45× | 3.22× | ||
| Q2 25 | 2.58× | 2.79× | ||
| Q1 25 | 1.93× | 34.71× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 3.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GHC
| Products | $602.7M | 48% |
| Kaplan International | $251.9M | 20% |
| Manufacturing | $117.8M | 9% |
| Television Broadcasting | $110.5M | 9% |
| Higher Education | $83.8M | 7% |
| Supplemental Education | $74.9M | 6% |
| Related Party | $4.4M | 0% |
ONC
Segment breakdown not available.
